Clinical effect of CALR allele burden in patients with essential thrombocythemia

Ann Hematol. 2022 Jun;101(6):1345-1346. doi: 10.1007/s00277-021-04717-3. Epub 2021 Nov 6.

Authors

Irene Bertozzi¹, Giacomo Biagetti², Tommaso Vezzaro², Isabella Barzon², Marco Carraro², Fabrizio Fabris², Maria Luigia Randi²

Affiliations

¹ Department of Medicine-DIMED, University of Padua, Via Giustiniani 2, 35128, Padua, Italy. irene.bertozzi@gmail.com.
² Department of Medicine-DIMED, University of Padua, Via Giustiniani 2, 35128, Padua, Italy.

PMID: 34743237
DOI: 10.1007/s00277-021-04717-3

No abstract available

Publication types

Letter

MeSH terms

Alleles
Calreticulin* / genetics
Humans
Janus Kinase 2 / genetics
Mutation
Receptors, Thrombopoietin / genetics
Thrombocythemia, Essential* / genetics

Substances

CALR protein, human
Calreticulin
Receptors, Thrombopoietin
Janus Kinase 2